Related Experiment Video
Updated: Jun 27, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
[Immunology and BCG therapeutics]
Manuel Anastacio Sánchez Olivas1, Martha Patricia Valencia Zavala, José Montes Montes
1Servicio de alergia e inmunología clínica, Hospital General de México, SS.
The Bacillus of Calmette-Guérin (BCG) is crucial for its immunological functions, including preventing tuberculosis spread and acting as an immunomodulator in cancer treatment. Further research into BCG strains can lead to more effective vaccines and therapies.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Context:
- Bacillus of Calmette-Guérin (BCG) plays a significant role in modulating the immune system.
- BCG's applications extend to preventing tuberculosis dissemination and serving as an immunomodulator in oncologic conditions.
- Its use is noted in treating vesical cancer to prevent post-surgical recurrence and in immunotherapy, including cytokine treatments.
Purpose:
- To highlight the multifaceted importance of studying Bacillus of Calmette-Guérin (BCG).
- To underscore BCG's established roles in immunology and oncology.
- To emphasize the need for continued research into BCG strains for enhanced therapeutic applications.
Summary:
- The study emphasizes the immunological significance of Bacillus of Calmette-Guérin (BCG).
- BCG is vital for preventing tuberculosis dissemination and acts as an immunomodulator in oncologic diseases like bladder cancer.
- It is also used in immunotherapy and melanoma treatment, with specific strains like Tice being crucial for superficial bladder cancer.
Impact:
- Continued research on BCG strains can yield more potent vaccines against tuberculosis.
- BCG's immunomodulatory properties offer therapeutic potential in various oncologic conditions.
- Understanding BCG's mechanisms can advance immunotherapy and disease prevention strategies.
More Related Videos
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Tumor Immunotherapy
Microorganisms in Medicine and Therapeutics
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...